- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05465109
Traumatic Brain Injury and Alzheimer's Disease/Related Dementias Caregiver Support Intervention (TACSI)
August 9, 2023 updated by: University of Minnesota
Designing and Evaluating a Comprehensive Support Program for Families Caring for Relatives Living With TBI-AD/ADRD
The TBI-AD/ADRD Caregiver Support Intervention (TACSI) incorporates psychosocial and psychoeducational approaches with the objective of: a) identifying stressors associated with caregiving for family members who have the dual diagnosis of traumatic brain injury and dementia; and b) supporting caregivers in developing more effective coping and communication strategies as well as enhanced caregiving self-efficacy.
Study Overview
Status
Recruiting
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
95
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Joseph E. Gaugler, PhD
- Phone Number: 612-626-2485
- Email: gaug0015@umn.edu
Study Locations
-
-
Minnesota
-
Minneapolis, Minnesota, United States, 55455
- Recruiting
- University of Minnesota
-
Contact:
- Joseph Gaugler, PhD
- Phone Number: 612-626-2485
- Email: gaug0015@umn.edu
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
21 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- the care recipient has a physician diagnosis of TBI and AD/ADRD (i.e., those with a diagnosis of both TBI and progressive cognitive decline)
- the caregiver self-identifies as someone who provides the most help/is most responsible for the person with TBI-AD/ADRD because of their cognitive impairments (or shares the role equally with another caregiver)
- the caregiver indicates a willingness to participate in the TACSI evaluation
- the caregiver is English speaking
- the caregiver is 21 years of age or older
- the caregiver is not currently participating in any other type of service that provides one-to-one psychosocial consultation or caregiver coaching (peer mentorship/support group participation/general counseling not specific to caregiving is not a deterrent to enrollment) at the discretion of the UMN research team
- the caregiver resides in the US.
Exclusion Criteria:
- caregivers who have a new or worsening mental health condition and are not receiving ongoing treatment. When applicable, if caregivers have not remained on a stable psychotropic medications dosage, such as antidepressants, anxiolytics or anti-psychotics, for the prior three months they will be excluded.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: TACSI
|
The TBI-AD/ADRD Caregiver Support Intervention (TACSI) incorporates psychosocial and psychoeducational approaches with the objective of: a) identifying stressors associated with caregiving for family members who have the dual diagnosis of traumatic brain injury and dementia; and b) supporting caregivers in developing more effective coping and communication strategies as well as enhanced caregiving self-efficacy.
This intervention offers individual and family coaching and knowledge and skills to help manage stress and reduce caregiver burden.
|
No Intervention: Usual care control group
The usual care control group would have continued receipt of standard services at either the Mayo Clinic or the MVAHCS.
In addition, staff will offer participants the opportunity to request supportive/educational resources as needed after randomization.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Caregiver primary subjective stress- Phase 1
Time Frame: change in score from baseline to 3 months
|
Change in score from baseline to Module 6
|
change in score from baseline to 3 months
|
Caregiver primary subjective stress- Phase 2, 3mo
Time Frame: change in score from baseline to 3 months
|
Change in score from baseline to Module 6
|
change in score from baseline to 3 months
|
Caregiver primary subjective stress- Phase 2, 6mo
Time Frame: change in score from baseline to 6 months
|
Change in score from baseline to Module 6
|
change in score from baseline to 6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 1, 2022
Primary Completion (Estimated)
July 1, 2024
Study Completion (Estimated)
July 1, 2024
Study Registration Dates
First Submitted
July 15, 2022
First Submitted That Met QC Criteria
July 15, 2022
First Posted (Actual)
July 19, 2022
Study Record Updates
Last Update Posted (Actual)
August 14, 2023
Last Update Submitted That Met QC Criteria
August 9, 2023
Last Verified
August 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- STUDY00014886
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Caregiver Burden
-
University of North Carolina, Chapel HillNorth Carolina Department of Health and Human ServicesRecruitingCaregiver Burnout | Caregiver Stress | Care Giving Burden | Caregiver Wellbeing | Support, Family | Care BurdenUnited States
-
Uludag UniversityCompleted
-
University of Colorado, DenverRecruiting
-
Medical University of South CarolinaUniversity of DelawareCompletedBurnout, CaregiverUnited States
-
Washington University School of MedicineCompleted
-
Texas Tech UniversityNot yet recruitingGrief | Mental Health Issue | Burden, CaregiverUnited States
-
Texas Tech UniversityRecruitingGrief | Mental Health Issue | Burden, CaregiverUnited States
-
Women's College HospitalRecruitingCaregiver BurnoutCanada
-
Sakarya UniversityCompleted
-
Weill Medical College of Cornell UniversityNational Institute on Aging (NIA)RecruitingCaregiver BurnoutUnited States
Clinical Trials on TBI-AD/ADRD Caregiver Support Intervention (TACSI)
-
University of WashingtonNational Cancer Institute (NCI)Completed
-
National Institute of Nursing Research (NINR)Completed
-
City of Hope Medical CenterNational Cancer Institute (NCI)Completed
-
The Gerocenter Foundation for Research and DevelopmentCompletedQuality of Life | Depressive Symptoms | Psychological DistressFinland
-
University of ManchesterUnknownStudy of How Caregivers Help Patients Cope With Respiratory and Other Symptoms Caused by Lung CancerDepression | Fatigue | Lung Cancer | Dyspnea | Anxiety DisorderUnited Kingdom
-
City of Hope Medical CenterNational Cancer Institute (NCI)WithdrawnDepression | Fatigue | Anxiety Disorder
-
Columbia UniversityPatient-Centered Outcomes Research Institute; NYU Langone Health; Alzheimer's... and other collaboratorsCompletedDepressive Symptoms | BurdenUnited States
-
Rush University Medical CenterNational Institute on Aging (NIA)CompletedLewy Body Disease | Dementia With Lewy Bodies | Parkinson Disease DementiaUnited States
-
City of Hope Medical CenterCompletedBreast Cancer | Stage I Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Ductal Breast Carcinoma in SituUnited States
-
University of WashingtonNational Cancer Institute (NCI)CompletedDepression | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Anxiety Disorder | Psychosocial Effects of Cancer and Its Treatment | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Ductal Breast Carcinoma in Situ | Lobular Breast Carcinoma in SituUnited States